Table 8 Distribution of different well-known risk factors for cardiovascular mortality between the genotypes A/A and A/G or G/A amalgamated, of rs2228262 in the study population
Variable | Total pop | Females | Males | ||||||
|---|---|---|---|---|---|---|---|---|---|
A/A | A/G-G/G | p-value | A/A | A/G-G/G | p-value | A/A | A/G-G/G | p-value | |
n | 259 | 211 | 124 | 107 | 135 | 104 | |||
IHD,n (%) | 65 (25.1) | 45 (21.3) | 0.34 | 23 (18.5) | 21 (19.6) | 0.84 | 42 (31.1) | 24 (23.1) | 0.17 |
DM, n (%) | 90 (34.7) | 63 (29.9) | 0.26 | 41 (33.1) | 27 (25.2) | 0.19 | 49 (36.3) | 36 (34.6) | 0.79 |
NYHA III, n (%) | 57 (22.0) | 37 (17.5) | 0.23 | 27 (21.8) | 19 (17.8) | 0.45 | 30 (22.2) | 18 (17.3) | 0.35 |
AF, n (%) | 31 (12.0) | 15 (7.1) | 0.08 | 12 (9.7) | 6 (5.6) | 0.25 | 19 (14.1) | 9 (8.7) | 0.20 |
EF < 40%, n (%) | 19 (7.3) | 17 (8.1) | 0.77 | 6 (4.8) | 3 (2.8) | 0.43 | 13 (9.6) | 14 (13.5) | 0.35 |
Hb < 120 g/L, n (%) | 25 (9.7) | 26 (12.3) | 0.35 | 17 (13.7) | 16 (15.0) | 0.79 | 8 (2.2) | 10 (9.6) | 0.28 |